Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03047161 · ClinicalTrials.gov registry record
Electrophysiology of Fetal Arrhythmia
A clinical trial of Fetal Arrhythmia, sponsored by University of Wisconsin, Madison.
- Recruiting
- Registry status
- 450
- Enrollment target
- 1
- Study location
NCT03047161: Recruiting study of Fetal Arrhythmia, sponsored by University of Wisconsin, Madison.
NCT03047161 is a study of Fetal Arrhythmia that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 450 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03047161, a study of Fetal Arrhythmia, is actively recruiting participants, sponsored by University of Wisconsin, Madison.
- RECRUITING
- Registry status
- 450 participants
- Enrollment target
- 1
- Study location
Study Summary
Fetal research and clinical practice has been hampered by a lack of suitable investigational techniques. Currently, ultrasound is the only widely used method of studying fetal anatomy and physiology, but it has significant limitations for assessment of cardiac rhythm. The proposed study will allow the investigators to evaluate fetal magnetocardiography (fMCG) as a new tool for the study of normal and abnormal fetal heart rate and rhythm.
Primary Outcome
fetal MCG rhythm assessment
Conditions Studied
Interventions
- DEVICE fetal MCG
Study Locations (1)
Wisconsin
- University of Wisconsin-Madison - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2017-02-07 |
| Est. Completion | 2028-05-30 |
What NCT03047161 shows while recruiting
NCT03047161 is an observational study that tracks outcomes without assigning an intervention. The registered 450 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Fetal Arrhythmia appearing as the primary indexed condition, and to 1 intervention - of which fetal MCG is the first listed.
NCT03047161 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT03047161 about?
NCT03047161 is a clinical study titled "Electrophysiology of Fetal Arrhythmia". Fetal research and clinical practice has been hampered by a lack of suitable investigational techniques. Currently, ultrasound is the only widely used method of studying fetal anatomy and physiology, but it has significant limitations for assessment of cardiac rhythm. The proposed study will allow t...
What is the current status of trial NCT03047161?
This trial is currently recruiting. The enrollment target is 450 participants. The study started on 2017-02-07. Estimated completion is 2028-05-30.
What conditions does trial NCT03047161 study?
This clinical trial studies the following conditions: Fetal Arrhythmia.
What interventions are being tested in trial NCT03047161?
The interventions under investigation include: fetal MCG (DEVICE).
Who is sponsoring clinical trial NCT03047161?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03047161 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fetal Arrhythmia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00515060 · 450 participants
Psychophysical Studies of Cancer Therapy Pain
- NCT01257269 · 450 participants
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
- NCT03269630 · 450 participants
New Orleans Pulmonary Hypertension Biobank
- NCT04165070 · 450 participants · Phase 1
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI